While CD14+CD16− monocytes have been initially reported to predict cardiovascular events, [32] a subsequent work showed that a different subset with more markedly inflammatory functions and with no murine counterpart, the intermediate CD14hiCD16+ monocytes, has been implicated as a key cell type in the development of atherosclerosis [30]. Here, CD14 is linked to atherosclerosis.